ChartRow logo
ARGX
argenx SE American Depositary SharesStock · Health Care
$990.32-0.55%
as of market close, Sep 18, 2026
☾ AH
PeersMRNALLYUNHJNJMRKTMO

ARGX financial statements

The full income statement, balance sheet, and cash-flow statement for argenx SE American Depositary Shares (ARGX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2017-12 32.2M2018-12 36.0M2019-12 42.8M2020-12 47.6M2021-12 51.7M2022-12 55.4M2023-12 59.2M2024-12 60.8M2025-12 61.9M+92.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue35.5M+254.4%10.0M-98.0%497M+1105.7%
Cost of revenue451M+98.3%227M+92.9%118M+300.4%29.4M
Research & development1.36B+38.7%983M+14.4%859M+29.6%663M+14.3%581M+56.5%
Operating income1.05B+4966.6%-21.7M+94.9%-425M+41.0%-720M-106.6%-349M+27.0%
Interest expense4.08M+65.7%2.46M+172.0%906K-76.8%3.91M-14.7%4.58M-42.5%
Pre-tax income1.28B+1401.1%85.2M+128.0%-304M+58.2%-729M-82.4%-400M+34.0%
Income tax-13.4M+98.2%-748M-7819.7%-9.44M+52.1%-19.7M-331.4%8.52M+174.6%
1.29B+55.1%833M+382.3%-295M+58.4%-710M-73.8%-408M+32.9%
Net income to common1.29B+55.1%833M+382.3%-295M+58.4%-710M-73.8%-408M+32.9%
$19.57+53.1%$12.78+347.7%-$5.16+60.5%-$13.05-63.3%-$7.99+40.4%
EPS (basic)$21.08+51.4%$13.92+369.8%-$5.16+60.5%-$13.05-63.3%-$7.99+40.4%
Weighted-avg shares (basic)61.3M+2.4%59.9M+4.7%57.2M+5.1%54.4M+6.5%51.1M+12.5%
Weighted-avg shares (diluted)66.0M+1.3%65.2M+14.0%57.2M+5.1%54.4M
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.90B+41.3%4.88B+18.4%4.12B+48.6%2.77B+9.1%2.54B+23.6%
Cash & equivalents3.49B+132.8%1.50B-26.8%2.05B+155.9%801M-40.0%1.33B+9.7%
Accounts receivable1.65B+82.1%904M+82.1%497M+80.2%276M+621.3%38.2M+447.7%
Inventory474M+16.3%407M+31.1%311M+36.0%228M+109.4%109M+332.9%
8.68B+40.0%6.20B+36.5%4.54B+44.9%3.13B+10.0%2.85B+25.0%
Property, plant & equipment22.7M+39.7%16.2M+2.5%15.8M+36.8%
Total non-current assets1.78B+35.2%1.32B+215.1%419M+16.3%360M+17.2%307M+38.2%
Total current liabilities1.32B+97.1%670M+58.4%423M+39.9%302M+0.3%301M-8.3%
Total liabilities1.36B+93.1%704M+58.3%445M+38.8%321M+1.4%316M-47.8%
7.32B+33.2%5.50B+34.2%4.10B+45.6%2.81B+11.0%2.53B+51.4%
Total equity incl. non-controlling7.32B+33.2%5.50B+34.2%4.10B+45.6%2.81B+11.0%2.53B+51.4%
Common shares outstanding61.9M+1.8%60.8M+2.6%59.2M+6.9%55.4M+7.2%51.7M+8.6%
Shares outstanding (cover)61.9M+1.8%60.8M+2.6%59.2M+6.9%55.4M+7.2%51.7M+8.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash from operations685M+928.1%-82.7M+80.3%-420M+51.3%-863M-42.2%-607M-52.3%
Acquisitions0.000.000.000.000.00
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.00-100.0%1.20B+57.3%761M-30.3%1.09B+34.2%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap52.0B+39.3%37.4B+77.3%21.1B+7.7%19.6B+8.2%18.1B+29.3%
P/E40.3×-10.2%44.9×
P/S1464.6×+39.3%1051.6×-50.0%2102.0×+5240.2%39.4×+8.2%36.4×-89.3%
P/B7.1×+4.6%6.8×-9.3%7.5×-3.0%7.7×+8.2%7.1×-14.6%
Earnings yield2.5%+11.4%2.2%
Source filing20-F20-F20-F20-F20-F

About this data

Source: ARGX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ARGX filings on SEC EDGAR → Not investment advice.